Literature DB >> 11674154

Semisynthetic Enzymes in Asymmetric Synthesis: Enantioselective Reduction of Racemic Hydroperoxides Catalyzed by Seleno-Subtilisin.

Dietmar Häring1, Ellen Schüler, Waldemar Adam, Chantu R. Saha-Möller, Peter Schreier.   

Abstract

The serine protease subtilisin was chemically converted into the peroxidase-active seleno-subtilisin. This semisynthetic enzyme catalyzes the enantioselective reduction of racemic hydroperoxides in the presence of thiophenols to yield optically active hydroperoxides and alcohols on the semipreparative scale. The kinetic parameters and enantioselectivities of seleno-subtilisin-catalyzed reduction of various chiral hydroperoxides were determined. The catalytic efficiency of this semisynthetic enzyme is comparable to that of the native horseradish peroxidase. The sense in the enantioselectivity of the seleno-subtilisin is opposite to the natural enzymes previously used in the synthesis of optically active hydroperoxides. Consequently, the semisynthetic enzyme seleno-subtilisin complements the naturally available peroxidases for the asymmetric synthesis of both enantiomers.

Entities:  

Year:  1999        PMID: 11674154     DOI: 10.1021/jo981665a

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  3 in total

Review 1.  Metallopeptide catalysts and artificial metalloenzymes containing unnatural amino acids.

Authors:  Jared C Lewis
Journal:  Curr Opin Chem Biol       Date:  2014-12-26       Impact factor: 8.822

2.  The role of streptavidin and its variants in catalysis by biotinylated secondary amines.

Authors:  Alexander R Nödling; Nicolò Santi; Raquel Castillo; Magdalena Lipka-Lloyd; Yi Jin; Louis C Morrill; Katarzyna Świderek; Vicent Moliner; Louis Y P Luk
Journal:  Org Biomol Chem       Date:  2021-12-08       Impact factor: 3.876

Review 3.  Enabling protein-hosted organocatalytic transformations.

Authors:  Alexander R Nödling; Nicolò Santi; Thomas L Williams; Yu-Hsuan Tsai; Louis Y P Luk
Journal:  RSC Adv       Date:  2020-04-23       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.